Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Scherma

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Neuropharmacology|October 2, 2007
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibitionMaria Scherma, Julie Medalie, Walter Fratta, et al.
Frontiers in Pharmacology|April 2, 2014
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanismsPetra Amchova, Jana Kucerova, Valentina Giugliano, et al.
The International Journal of Eating Disorders|April 11, 2020
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosaClaudio D'Addario, Elizabeta Zaplatic, Elisa Giunti, et al.
Brain, Behavior, and Immunity|February 6, 2023
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspringMichele Santoni, Claudia Sagheddu, Valeria Serra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2015
Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult RatsMaria Scherma, Christian Dessì, Anna Lisa Muntoni, et al.
British Journal of Pharmacology|May 12, 2011
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in ratsMaria Scherma, Zuzana Justinová, Claudio Zanettini, et al.
Cell Reports|March 15, 2018
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent RatsPhilippe A Melas, Johanna S Qvist, Matteo Deidda, et al.
Frontiers in Psychiatry|April 23, 2025
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depressionEnrico Ginelli, Lucia Sanna, Pasquale Paribello, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2020
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaineMaria Scherma, Johanna S Qvist, Arun Asok, et al.
International Journal of Molecular Sciences|November 17, 2020
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein OligomersLaura Boi, Augusta Pisanu, Maria Francesca Palmas, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Neuropharmacology|October 2, 2007
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibitionMaria Scherma, Julie Medalie, Walter Fratta, et al.
Frontiers in Pharmacology|April 2, 2014
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanismsPetra Amchova, Jana Kucerova, Valentina Giugliano, et al.
The International Journal of Eating Disorders|April 11, 2020
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosaClaudio D'Addario, Elizabeta Zaplatic, Elisa Giunti, et al.
Brain, Behavior, and Immunity|February 6, 2023
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspringMichele Santoni, Claudia Sagheddu, Valeria Serra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2015
Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult RatsMaria Scherma, Christian Dessì, Anna Lisa Muntoni, et al.
British Journal of Pharmacology|May 12, 2011
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in ratsMaria Scherma, Zuzana Justinová, Claudio Zanettini, et al.
Cell Reports|March 15, 2018
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent RatsPhilippe A Melas, Johanna S Qvist, Matteo Deidda, et al.
Frontiers in Psychiatry|April 23, 2025
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depressionEnrico Ginelli, Lucia Sanna, Pasquale Paribello, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2020
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaineMaria Scherma, Johanna S Qvist, Arun Asok, et al.
International Journal of Molecular Sciences|November 17, 2020
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein OligomersLaura Boi, Augusta Pisanu, Maria Francesca Palmas, et al.
Pageof 6